Dr. Mehmet Bilen, MD
Claim this profileEmory University Hospital/Winship Cancer Institute
Studies Cancer
Studies Prostate Cancer
13 reported clinical trials
40 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
2Prostate Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Mehmet Bilen, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
Cabozantinib + Enfortumab Vedotin
for Bladder Cancer
This phase I/Ib trial seeks to find out the best dose, possible benefits and/or side effects of cabozantinib in combination with enfortumab vedotin in treating urothelial cancer that has spread to nearby tissues and lymph nodes (locally advanced) or other parts of the body (metastatic). Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Enfortumab vedotin is a monoclonal antibody, enfortumab, linked to a toxic agent called vedotin. Enfortumab attaches to nectin-4 tumor cells in a targeted way and delivers vedotin to kill them. Cabozantinib in combination with enfortumab vedotin may be safe and effective in treating locally advanced or metastatic urothelial cancer.
Recruiting3 awards Phase 110 criteria
More about Mehmet Bilen, MD
Clinical Trial Related2 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Mehmet Bilen, MD has experience with
- Nivolumab
- Ipilimumab
- Cabozantinib S-malate
- Abemaciclib
- Abiraterone
- Enfortumab Vedotin
Breakdown of trials Mehmet Bilen, MD has run
Cancer
Prostate Cancer
Bladder Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mehmet Bilen, MD specialize in?
Mehmet Bilen, MD focuses on Cancer and Prostate Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Mehmet Bilen, MD currently recruiting for clinical trials?
Yes, Mehmet Bilen, MD is currently recruiting for 6 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Mehmet Bilen, MD has studied deeply?
Yes, Mehmet Bilen, MD has studied treatments such as Nivolumab, Ipilimumab, Cabozantinib S-malate.
What is the best way to schedule an appointment with Mehmet Bilen, MD?
Apply for one of the trials that Mehmet Bilen, MD is conducting.
What is the office address of Mehmet Bilen, MD?
The office of Mehmet Bilen, MD is located at: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital/Winship Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.